Augurex Announces Mayo Clinic Laboratories Now Offering 14-3-3eta Testing for Rheumatoid Arthritis

Mayo Clinic Laboratories adds 14-3-3eta serum testing to its diagnostic testing portfolio, expanding access to an important biomarker for rheumatoid arthritis VANCOUVER, British Columbia — Augurex Life Sciences Corp., a commercial-stage diagnostics company focused on autoimmune and inflammatory diseases, today announced that Mayo Clinic Laboratories is now offering 14-3-3eta serum testing for rheumatoid arthritis (RA) […]